Low-dose estrogen therapy shown to be very effective on vasomotor symptoms

Low-dose estrogen therapy revealed to be really effective on vasomotor symptoms

For early postmenopausal females worried about the efficiency of low-dose estrogen therapy for reducing menopause symptoms such as hot flashes, night sweats, sleeping disorders, and irritability, information from the Kronos Early Estrogen Prevention Study (KEEPS) was utilized to compare the effectiveness of two forms of hormonal agent treatment (HT) on menopause symptoms compared with placebo over 4 years. Results of the research study were released in the journal of The North American Menopause Society, Menopause. The majority of perimenopausal women will experience some kind of menopause sign. The beginning or significant boosts of vasomotor signs (VMS; hot flashes and night sweats) are reported by as much as 85% of females at menopause, and although the link in between reducing estrogen levels and VMS is well known, fewer research studies have taken a look at the link in between hormonal agents and less widespread signs such as depressed mood, sleeping disorders, and irritability, and few studies have compared HT regimens throughout extended periods. KEEPS was a multicenter medical trial created to compare impacts of low-dose oral conjugated estrogens (CEE) with those of transdermal estradiol versus placebo on cardiovascular endpoints in recently postmenopausal w.
See all stories on this topic

No Comments

Post a Comment